Serial Study Group definition

Serial Study Group means the collection of valid Interconnection Requests with an assigned Queue Position on or before June 1, 2008 studied in accordance with the interconnection procedures set forth in the version of the GIP set forth in CAISO Tariff Appendix U as permitted by the decision of FERC in Docket No. ER08-960-000.
Sample 1Sample 2Sample 3
Serial Study Group means the collection of valid Interconnection Requests with an assigned Queue Position on or before June 1, 2008 studied in accordance with the interconnection
Sample 1

Examples of Serial Study Group in a sentence

  • The objective of this Appendix 8 to the Generator Interconnection Procedures (GIP) is to implement the requirements for interconnecting to the CAISO Controlled Grid those Generating Facilities assigned to the SGIP Serial Study Group or SGIP Transition Cluster.

  • The need for this waiver arises from the fact that the Serial Study Group, Transition Cluster, and the Initial GIPR Cluster must be studied sequentially and the processing timelines for the Serial Study Group and Transition Cluster exceed 180 days.

  • Based on these criteria, the Serial Study Group is projected to include 85 of the projects in the queue, 60 of which are in the serial study phase or later.

  • Based on the estimated timing to complete the Serial Study Group requests, CAISO expects to begin work on the Transition Cluster requests by November 2008, with all studies completed by July 2009.

  • CAISO submitted its reform proposal filing to FERC on July 28, 2008,24 and received approval on September 26, 2008.25 CAISO proposed three study groups as a transition strategy: the Serial Study Group, the Transition Cluster, and the Initial Generation Interconnection Process Reform (GIPR) Cluster.

  • The Serial Study Group will continue to be studied in accordance with the existing LGIP.

  • CAISO does not anticipate or intend on processing interconnection requests received during the initial queue cluster window until the interconnection requests submitted prior to June 2008 are fully studied as part of either the Serial Study Group or the Transition Cluster Study Group.

  • The Serial Study Group should include approximately 25 percent of the proposed renewable energy projects, slightly more than 12,000 MW.

  • According to Tariff Appendix Y, Appendix 8, Section 1.2.2, the "SGIP Serial Study Group" means those Interconnection Customers with valid Interconnection Requests submitted pursuant to Appendix S of the CAISO Tariff prior to December 18, 2010 and who executed System Impact Study or Facilities Study Agreements that provide for the completion of such studies by December 18, 2010.

  • CAISO plans to suspend the study activities for those projects in the Transition Cluster until all studies in the Serial Study Group are completed, expected to be about July 2009.All interconnection requests that are received by CAISO after June 2, 2008, will be placed in the Initial GIPR Cluster study group and subject to a temporary suspension.

Related to Serial Study Group

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Pivotal Clinical Trial means a human clinical trial of a Licensed Product that (a) would satisfy the requirements of 21 C.F.R. 312.21(c) or corresponding foreign regulations; or (b) that is intended to provide sufficient efficacy data to support the Filing of a BLA for such Licensed Product in such country. A Pivotal Clinical Trial includes a Phase 2 Clinical Trial or Phase 3 Clinical Trial that satisfies the foregoing definition.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Phase III Clinical Trial means a large, controlled or uncontrolled Clinical Study that would satisfy the requirements of 21 CFR 312.21(c), intended to gather the additional information about effectiveness and safety that is needed to evaluate the overall benefit-risk relationship of the drug and to provide an adequate basis for physician labeling.

  • Phase 2 Trial means a human clinical trial conducted on study subjects with the disease or condition being studied for the principal purpose of achieving a preliminary determination of efficacy or appropriate dosage ranges, as further described in 21 C.F.R. §312.21(b) (including any such clinical study in any country other than the United States).

  • Pivotal Trial means (a) a Phase 2 Clinical Trial, or a combination Phase 2 Clinical Trial and Phase 3 Clinical Trial, that (taken together with any other trials completed prior to or concurrently with such trial) is intended to support Marketing Approval for a Product by the relevant Regulatory Authority in the indication under study, or (b) a Phase 3 Clinical Trial.

  • Phase I Trial means a clinical trial of a Licensed Product in human patients conducted primarily for the purpose of determining the safety, tolerability and preliminary activity of the Licensed Product, including, without limitation, for determining the maximum tolerated dose, or optimal dose. For purposes of this Agreement, a Phase I trial shall specifically exclude a study in healthy volunteers.

  • Clinical Studies means Xxxxx 0, Xxxxx 0, Xxxxx 0, Xxxxx 3, and such other tests and studies in human subjects that are required by Applicable Law, or otherwise recommended by the Regulatory Authorities, to obtain or maintain Regulatory Approvals for a Licensed Product for one (1) or more indications, including tests or studies that are intended to expand the Product Labeling for such Licensed Product with respect to such indication.

  • Class Year Study means a Class Year Interconnection Facilities Study as that term is defined in OATT Section 25 (OATT Attachment S).

  • Phase 1 Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of Licensed Product or that would otherwise satisfy the requirements of 21 C.F.R. 312.21(a) or an equivalent clinical trial in a country in the Territory other than the United States.